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Abstract
Impulsivity and hyperactivity are two facets of attention deficit/hyperactivity disorder (ADHD). 
Impulsivity is expressed as reduced response inhibition capacity, an executive control mechanism 
that prevents premature execution of an intermittently reinforced behavior. During 
methylphenidate treatment, impulsivity and hyperactivity are decreased in adolescents with 
ADHD, but there is little information concerning levels of impulsivity and hyperactivity in 
adulthood after adolescent methylphenidate treatment is discontinued. The current study evaluated 
impulsivity, hyperactivity as well as cocaine sensitization during adulthood after adolescent 
methylphenidate treatment was discontinued in the Spontaneously Hypertensive Rat (SHR) model 
of ADHD. Treatments consisted of oral methylphenidate (1.5 mg/kg) or water vehicle provided 
Monday-Friday from postnatal day 28–55. During adulthood, impulsivity was measured in SHR 
and control strains (Wistar Kyoto and Wistar rats) using differential reinforcement of low rate 
(DRL) schedules. Locomotor activity and cocaine sensitization were measured using the open-
field assay. Adult SHR exhibited decreased efficiency of reinforcement under the DRL30 schedule 
and greater levels of locomotor activity and cocaine sensitization compared to control strains. 
Compared to vehicle, methylphenidate treatment during adolescence reduced hyperactivity in 
adult SHR, maintained the lower efficiency of reinforcement, and increased burst responding 
under DRL30. Cocaine sensitization was not altered following adolescent methylphenidate in 
adult SHR. In conclusion, adolescent treatment with methylphenidate followed by discontinuation 
in adulthood had a positive benefit by reducing hyperactivity in adult SHR rats; however, 
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increased burst responding under DRL compared to SHR given vehicle, i.e., elevated impulsivity, 
constituting an adverse consequence associated with increased risk for cocaine abuse liability.
Keywords
Attention Deficit/Hyperactivity Disorder; Impulsivity; Differential Reinforcement of Low Rates 
Schedule; Methylphenidate; Spontaneously Hypertensive Rat
1 Introduction
Attention-deficit/hyperactivity disorder (ADHD), a neurobehavioral disorder affecting 12% 
of children and 5% of adults (Biederman, Petty et al. 2010), is characterized by increased 
impulsivity, hyperactivity and inattention (Bearden, Reus et al. 2004, Castellanos, Sonuga-
Barke et al. 2005, American Psychiatric Association. 2013). Impulsivity, a broad 
psychological construct, encompasses a variety of maladaptive behaviors, e.g., actions that 
are poorly conceived, unnecessarily risky and prematurely executed without sufficient 
forethought (Evenden 1999). Response inhibition capacity, an endophenotype of impulsivity 
(Almasy and Blangero 2001, Gottesman and Gould 2003, Slaats-Willemse, Swaab-
Barneveld et al. 2003, Crosbie, Perusse et al. 2008), is an executive control mechanism 
preventing premature execution of intermittently reinforced actions (Barkley 1997, Aron 
2007). Deficits in response inhibition are reported in ADHD (Clark, Blackwell et al. 2007, 
Crosbie, Perusse et al. 2008).
Methylphenidate (MPH), the most widely prescribed pharmacotherapy for ADHD 
(Goldman, Genel et al. 1998, Robison, Sclar et al. 1999, CDC 2007), increases response 
inhibition capacity in children and adolescents with ADHD (Rhodes, Coghill et al. 2006, 
Coghill, Rhodes et al. 2007). Therapeutic effects of MPH are due, in part, to increased 
extracellular dopamine (DA) in prefrontal cortex (Berridge, Devilbiss et al. 2006, Berridge 
and Devilbiss 2011). Adolescence represents a vulnerable period for cortical neuronal 
development, and during this period, MPH treatment may alter the normal developmental 
trajectory of the prefrontal cortex (Chambers, Taylor et al. 2003, Casey and Jones 2010, 
Counotte, Smit et al. 2011). Regarding long-term consequences, studies in outbred rats show 
that low doses of MPH during adolescence decrease impulsive choice during adulthood, 
such that delayed larger rewards are chosen over immediate smaller rewards (Adriani, 
Canese et al. 2007). Other beneficial long-term consequences of MPH treatment in outbred 
adolescent rats include the absence of an increase in the psychomotor response to cocaine 
(Brandon, Marinelli et al. 2001) and increases in prefrontal cortical neuron excitability and 
phosphocreatine/creatine ratios, indicating increased energy utilization during adulthood 
(Adriani, Canese et al. 2007, Urban, Waterhouse et al. 2012, Urban, Li et al. 2013). 
However, outbred rats do not adequately model deficits in ADHD, such as increased 
impulsivity, inattention and enhanced sensitivity to reinforcement delays (Russell, de 
Villiers et al. 1995, Sagvolden, Aase et al. 1998, Sagvolden, Russell et al. 2005). Thus, 
MPH given during adolescence may produce different outcomes in rats exhibiting an ADHD 
phenotype.
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The Spontaneously Hypertensive Rat (SHR), the most widely accepted model of ADHD, 
displays many phenotypic characteristics of ADHD, including impulsivity (Adriani, Caprioli 
et al. 2003, Mill, Sagvolden et al. 2005, Sagvolden, Russell et al. 2005, Sanabria and Killeen 
2008). Wistar-Kyoto (WKY), an inbred progenitor strain from which SHR are derived, and 
Wistar (WIS), an outbred strain and common ancestor of SHR and WKY, are controls for 
SHR. Of note, WKY from Charles River/GER, a model for the predominantly inattentive 
subtype of ADHD (Sagvolden, Dasbanerjee et al. 2008), have a large number (35%) of 
discordant SNP genotypes relative to WKY from Harlan/UK, a well-recognized control for 
SHR (Sagvolden, Johansen et al. 2009). In contrast, WKY from Charles River/US have a 
small number (2.5%) of discordant SNP genotypes relative to WKY from Harlan/UK 
(Zhang-James, Middleton et al. 2013), and are not expected to differ from WKY from 
Harlan/UK. Thus, WKY from Charles River/US were used as the inbred control herein. 
Outbred controls (e.g., WIS) were also used, as they help to disambiguate differences 
between SHR and WKY, and control for the hyper-responsiveness to acute stress exhibited 
by WKY from Charles River and Harlan (Pare and Kluczynski 1997, De La Garza and 
Mahoney 2004, Alsop 2007, Langen and Dost 2011).
In SHR, chronic oral MPH at therapeutically relevant doses improves cognitive deficits 
(Kantak, Singh et al. 2008, Harvey, Jordan et al. 2013). However, chronic MPH 
administered to adolescent SHR also produces maladaptive sequelae, including increased 
anxiety and cross-sensitization to cocaine (Vendruscolo, Izidio et al. 2008, Yetnikoff and 
Arvanitogiannis 2013). Moreover, chronic MPH treatment during adolescence, followed by 
treatment discontinuation, increases cocaine self-administration in adult SHR compared to 
SHR receiving vehicle and compared to WKY and WIS given MPH or vehicle (Harvey, Sen 
et al. 2011). In contrast, WIS treated with MPH show reduced acquisition of cocaine self-
administration compared to vehicle control during adulthood (Harvey, Sen et al. 2011), 
consistent with previous reports using outbred rats (Carlezon, Mague et al. 2003, Thanos, 
Michaelides et al. 2007). Further, chronic MPH in adolescent SHR decreases markers of 
neuronal plasticity in adolescent prefrontal cortex (Fumagalli, Cattaneo et al. 2010), 
suggesting that the prefrontal cortex may be critical in modulating the long-term 
consequences of MPH treatment during adolescence. Chronic MPH during adolescence 
increases DA transporter (DAT) function in SHR medial prefrontal cortex (mPFC) 
(Somkuwar, Darna et al. 2013), suggesting decreased extracellular DA during adulthood, 
long after discontinuation of MPH treatment. Decreased mPFC DA is associated with 
increased responsiveness to cocaine and increased response inhibition deficits in a 
differential reinforcement of low rate (DRL) 30 s schedule (Schenk, Horger et al. 1991, 
Sokolowski and Salamone 1994). Although not empirically determined, these previous 
findings suggest that chronic MPH treatment during adolescence leads to increased deficits 
in response inhibition capacity and increased cocaine sensitivity during adulthood, 
specifically in SHR.
The current study used DRL schedules in SHR to evaluate effects of MPH treatment during 
adolescence on response inhibition capacity during adulthood. Under a DRL schedule, 
subjects must wait for a defined time period between consecutive responses to earn a 
reinforcer, i.e., inter-response times (IRT) greater than an experimenter-defined minimum 
interval are reinforced (Monterosso and Ainslie 1999). Deficits in response inhibition 
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capacity (or premature responding) are inferred from the reduced efficiency of earning 
reinforcers (Stein and Landis 1975). Increased reinforcement density reduces behavioral 
deficits in individuals with ADHD and in SHR (Wultz and Sagvolden 1992; Aase and 
Sagvolden 2006). Compared to WIS, deficits in SHR are reported under relatively difficult 
tasks in strategy set-shifting schedules (Harvey, Jordan et al. 2013). Thus, DRL 5 s limited 
hold (DRL5LH) and DRL 30 s (DRL30) with a high and low reinforcement density, 
respectively, evaluated response inhibition capacity herein. Short DRL schedules, including 
DRL30, are sensitive to effects of ADHD medications (Peterson, Wolf et al. 2003, 
Hankosky and Gulley 2013). Compared to WKY and several outbred strains, adult SHR 
exhibit reduced efficiency under DRL schedules (Bull, Reavill et al. 2000, van den Bergh, 
Bloemarts et al. 2006, Ferguson, Paule et al. 2007, Sanabria and Killeen 2008, Orduna, 
Valencia-Torres et al. 2009). In the present study, a novel modeling approach was used to 
analyze the microstructure of DRL responding. Further, cocaine-induced hyperactivity and 
cocaine sensitization were measured in adult SHR, WKY and WIS to determine the long-
term consequences of adolescent MPH on cocaine-related behaviors other than self-
administration examined previously.
2 Methods
2.1 Subjects
Male SHR and WKY (Charles River Laboratories, Kingston, NY) and male WIS (Charles 
River Laboratories, Raleigh, NC) rats (postnatal day 25 [P25] upon arrival) were maintained 
on a 12-h light:dark cycle (on 07:00 h), and housed individually with free access to food and 
water. After 3 habituation days, rats were food-restricted to 90–95% of expected free-
feeding body weight. Group size (n=6/group) was based on previous studies using a 
quantitative modeling approach to evaluate behavior under DRL schedules (Sanabria and 
Killeen 2008, Hill, Covarrubias et al. 2012). The sequence of experiments, conducted during 
the light phase, is presented in Fig 1. Principles of laboratory animal care were followed; 
protocols were conducted according to the 2012 National Institutes of Health Guide for the 
Care and Use of Laboratory Animals and approved by the University of Kentucky 
Institutional Animal Care and Use Committee.
2.2 Drugs and treatments
(±)-Methylphenidate HCl (MPH; Sigma-Aldrich, St Louis, MO) dissolved in 1.5 mg/ml 
water was injected into oyster crackers for oral (p.o.) dosing (Kantak, Singh et al. 2008). 
Crackers injected with water (1 ml/kg) served as vehicle control. Cocaine HCl, a gift from 
the National Institute on Drug Abuse (Bethesda, MD, USA), was dissolved in sterile saline 
(0.9% w/v) at 10 mg/ml and injected at 10 mg/kg (i.p.) to determine acute locomotor 
activation and induction of sensitization. For expression of sensitization, cocaine solutions 
(5, 7.5 and 15 mg/ml) were prepared for doses ranging from 5–15 mg/kg (i.p.). Solutions 
were prepared fresh each day.
2.3 Methylphenidate treatment during adolescence
SHR, WKY and WIS were treated with MPH (1.5 mg/kg, p.o.) or vehicle from P28 to P55, 
early to late adolescence (Spear 2000, Doremus-Fitzwater, Varlinskaya et al. 2010). Given 
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inherent species differences in MPH absorption, distribution, metabolism and elimination, 
complete agreement has not been reached on the ideal method for arriving at clinically-
relevant MPH doses for preclinical studies. For the current series of experiments, a 1.5 
mg/kg dose of MPH was chosen as it produces therapeutically relevant plasma 
concentrations (9–36 ng/ml plasma) in rats (Wargin, Patrick et al. 1983, Kuczenski and 
Segal 2002), enhances extracellular DA and NE in the prefrontal cortex to improve 
cognitive function (Berridge, Devilbiss et al. 2006), and is below the threshold for producing 
hyperactivity (Gerasimov, Franceschi et al. 2000, Kuczenski and Segal 2002). This chronic 
regimen of MPH treatment improved working memory and visual discrimination learning in 
adolescent and adult SHR, but not in WKY and WIS (Kantak, Singh et al. 2008, Harvey, 
Sen et al. 2011). Doses were given Monday to Friday modeling weekend “medication 
holidays” in patients with ADHD (Martins, Tramontina et al. 2004). After P55, rats were 
maintained in their home cages with ad libitum access to food and water.
2.4 Differential reinforcement of low-rate schedules
Effects of MPH during adolescence on impulsivity in adulthood were determined using a 
DRL schedule in operant conditioning chambers (Supplementary Methods). Starting at P77, 
rats were food restricted to 90–95% of expected free-feeding body weight and trained in 
daily 55-min sessions under DRL5secLH, and subsequently in DRL30sec, as described 
previously (Sanabria and Killeen 2008); detailed in Supplementary Methods). For DRL30, 
LH was not employed because long IRTs are infrequent under DRL schedules with low 
reinforcement density (Richards, Sabol et al. 1993, Sanabria and Killeen 2008); 
Supplementary Results). Number of active and inactive lever responses, pellets earned, and 
IRTs were recorded over 5 sessions of stable performance. Response efficiency under 
DRL30 in SHR was ~6% (Supplementary Results), such that longer waiting times 
associated with longer DRLs may have resulted in a floor effect in response efficiency. 
Following completion of the DRL study, rats were maintained in the home cage with ad 
libitum access to food and water.
2.5 Open-field activity
Effect of MPH during adolescence on locomotor activity in adult rats was determined 3–5 
days after DRL study completion. SHR, WKY and WIS rats were habituated for 3 days 
during 1-hr sessions in acrylic open-field chambers (42 × 42 × 30 cm), each with a 16 × 16 
photobeam sensor grid and a monitoring system (AccuScan Instruments Inc., Columbus, 
OH). Activity was recorded during the 3 habituation days as horizontal beam breaks and 
repeated breaks to capture both gross and fine movements respectively..
2.5.1 Acute cocaine-induced hyperactivity—One day after the open-field activity 
assay, cocaine-induced hyperactivity was determined in the same open-field chambers. On 
consecutive days, rats were injected acutely with cocaine (10 mg/kg, i.p.) and saline (1 
ml/kg, i.p.) in a random order. Activity was recorded for 1 hr. Rats were not habituated to 
the injection procedure.
2.5.2 Sensitization to repeated cocaine administration—Following determination 
of acute cocaine-induced hyperactivity, all rats were administered cocaine (10 mg/kg, i.p., 
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once daily for 10 days), placed in the chambers for 1 hr and activity recorded. Strain 
differences and effects of adolescent MPH treatment on induction of cocaine sensitization 
were determined. Upon completion of the 10-day repeated treatment phase, rats remained 
undisturbed in the home cage for a 14-day cocaine-free period without access to the 
chambers. On the 15th day, expression of cocaine sensitization was determined by injecting 
cocaine (0, 5, 7.5 and 15 mg/kg, i.p., ascending dose order within a single 2-hr session); 
activity was monitored for 30 min after each dose. Note that the control was a volume 
matched saline injection and hence, is referred to saline in the corresponding results and 
figures for this experiment.
2.6 Data analysis
2.6.1 Modified temporal regulation (TR) model—Therapeutically relevant, acute 
doses of MPH do not alter efficiency of reinforcement under DRL (van den Bergh, 
Bloemarts et al. 2006, Ferguson, Paule et al. 2007, Orduna, Valencia-Torres et al. 2009). 
However, for evaluating MPH effects on response inhibition capacity under DRL, 
quantitative TR modeling of IRT-distribution patterns is more sensitive than is efficiency 
(Sanabria and Killeen 2008, Hill, Covarrubias et al. 2012). Modified TR models, quantifying 
IRT distributions obtained under DRL5LH and DRL30, are defined by Equations 1 and 2, 
respectively (Supplementary Methods; Fig S1). Both models segregate IRT distributions 
between timed IRTs expected to congregate near the target time (e.g., 5 s for DRL5LH, and 
30 s for DRL30), and non-timed, exponentially distributed IRTs (Sanabria and Killeen 2008, 
Hill, Covarrubias et al. 2012, Mika, Mazur et al. 2012).P(IRT = t) = pΓ(t − δ; N, c) + q(1 − 
p)Le−L(t−δ) + (1 − q)(1 − p)L′e−L′(t−δ) (EQ 1 for DRL5LH); P(IRT = t) = pΓ(t − δ; N, c) + (1 
− p)λe−λ(t−δ); 0 < δ < t (EQ 2 for DRL30). Parameters from mathematical models serve as 
dependent variables describing response inhibition capacity: (1) Response threshold θ = 
(Nxc)/5 s and (Nxc)/30 s for DRL5LH and DRL30, respectively, where (Nxc) is the mean of 
timed IRTs. θ <1 indicates reduced accuracy of timed IRTs. (2) Proportion of timed IRTs (p) 
is expressed as a fraction of all IRTs obtained from an individual rat. A large value for p 
indicates greater response inhibition capacity. (3) Proportion of burst IRTs (q*(1−p)) and 
(1−p) for DRL5LH and DRL30, respectively, is expressed as a fraction of all IRTs obtained 
from an individual rat. Burst IRTs are a component of non-timed IRTs. A greater proportion 
of burst IRTs indicates reduced response inhibition capacity. The model also provides 1/L 
and 1/λ, which are the mean burst IRTs for DRL5LH and DRL30, respectively, and the 
Weber-fraction (ω), an index of the precision of timing. Fraction m ((1−p)*(1−q)) and rate-
of-decay (L′) of long IRTs under DRL5LH characterize task-delinquent responses (McClure 
and McMillan 1997).
One WKY died prior to treatment initiation and data collection. All data were analyzed 
using SPSS Statistics Version 19 (SPSS Inc., IBM Company, Armonk, NY). Efficiency of 
reinforcement (% responses reinforced) and modeling dependent variables for response 
inhibition capacity were compared between groups. Data are reported as mean ± S.E.M.; n 
represents number of rats/group. For evaluating MPH effects, 2-factor ANOVA (strain X 
treatment) were followed by Bonferroni’s test corrected for multiple comparisons. Main 
effects of strain and treatment were evaluated using Tukey’s tests. Significance was assessed 
at α = 0.05. Under DRL30, proportion of burst IRTs emitted by one WKY given vehicle was 
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excluded as the value was identified as an outlier using the Grubbs test (GraphPad; http://
www.graphpad.com/quickcalcs/Grubbs1.cfm).
2.6.2 Open-field activity and cocaine sensitivity—Mean ± S.E.M. of total number of 
horizontal beam breaks, repeated breaks of the same beam, as well as percent time spent in 
the margins during 1-hr sessions of open-field activity (i.e., the last day of habituation), are 
presented. Temporal changes in open-field activity (last day of habituation) are reported as 
mean ± S.E.M. of horizontal beam breaks for every 5-min bin during the 1-hr session. For 
cocaine hyperactivity, total number of beam breaks and repeated breaks of the same beam 
are reported as mean ± S.E.M. during the 1-hr sessions following saline and cocaine 
injections. For induction of sensitization, total number of horizontal beam breaks are 
reported as mean ± S.E.M. during the daily 1-hr sessions. For expression of sensitization, 
mean ± S.E.M. for total number of beam breaks and number of repeated breaks of the same 
beam during the 30-min period after each cocaine dose are reported. Dependent measures 
for open-field activity were analyzed using 2-factor ANOVA with adolescent treatment (2 
levels) and strain (3 levels) as between-subject factors. Furthermore, temporal changes in 
open-field activity were evaluated using repeated measures 2-factor ANOVA with 
adolescent treatment and strain combination (6 levels) as between-subject factors and time 
(12 levels) as a within-subject factor. Cocaine hyperactivity and expression of sensitization 
were analyzed using repeated-measures 3-factor ANOVAs with cocaine dose as a within-
subject factor for hyperactivity (2 levels) and for expression of sensitization (4 levels). 
Mauchly’s tests of Sphericity tested the assumption of sphericity of variance for repeated-
measures ANOVAs. When sphericity was violated, Greenhouse-Geisser correction 
determined within-subject effects. Main effects and interactions were evaluated using 
Bonferroni’s post-hoc analyses corrected for multiple comparisons. For evaluating induction 
of sensitization, a 3-way repeated-measures ANOVA was conducted. Session (10 levels) 
served as a discreet within-subject variable and adolescent treatment (2 levels) and strain (3 
levels) as between-subject variables. Linear mixed model analyses have been shown to be 
more powerful statistical analyses compared to traditional repeated measures ANOVA, 
particularly, for data with large number of observations (Wainwright, Leatherdale et al. 
2007, Baayen, Davidson et al. 2008). Therefore, a complementary linear mixed model 
analysis was conducted (Verbeke and Molenberghs 2000) for induction of sensitization 
using session (10 levels) as a within-subject continuous variable and adolescent treatment (2 
levels) and strain (3 levels) as between-subject variables. Session x strain and session x 
treatment interactions were probed further using linear regression analyses to identify 
differences in rate of change of locomotor activity with repeated cocaine injections.
3 Results
3.1 Response inhibition capacity
Rats reached stability in DRL5LH within 12–16 sessions; IRT distribution patterns are 
presented for adult SHR, WKY and WIS administered MPH or vehicle during adolescence 
(Fig 2). MPH during adolescence in SHR did not alter percent of responses reinforced 
(efficiency; Table 1), proportions of timed IRTs and burst IRTs as well as mean timed IRTs 
(Supplementary Results, Fig S2), indicating no effect on impulsivity under DRL5LH in the 
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ADHD model. Strain differences were identified, such that percent of responses reinforced 
(i.e., efficiency) was lower in SHR compared to WIS and WKY (Table 1), indicating greater 
impulsivity in SHR compared to control. Surprisingly, WKY administered vehicle emitted a 
lower proportion of timed IRTs compared to WIS, and MPH treatment during adolescence 
normalized this measure of impulsivity in WKY (p; Finteraction[2, 29] = 5.19, p < 0.05; 
Supplementary Fig S2A).
Under DRL30, rats required 17–22 sessions to reach stability; mean IRT distribution 
patterns are presented for SHR, WKY and WIS administered MPH or vehicle during 
adolescence (Fig 3A). A main effect of strain was found for efficiency (Fstrain[2,29] = 32.9, 
p<0.05; Table 1), with SHR < WKY and WIS, suggesting greater impulsivity in SHR; main 
effect of treatment and the strain x treatment interaction were not significant. A main effect 
of strain for accuracy of timed IRTs was found (θ; Fstrain[2,29] = 32.9, p<0.0001; Fig 3B), 
with SHR<WIS<WKY; main effect of treatment and the strain x treatment interaction were 
not significant. Moreover, a strain x treatment interaction was found for proportion of burst 
IRTs emitted ((1−p); Finteraction[2,28] = 3.58, p<0.05; Fig 3C), with SHR > WKY and WIS 
after vehicle. Importantly, adolescent MPH further increased burst IRTs only in SHR during 
adulthood (p<0.05). Thus, adult SHR were more impulsive than control WKY and WIS, and 
adolescent MPH further increased impulsivity in adult SHR, as indicated by an increased 
proportion of burst IRTs under DRL30.
3.2 Open-field activity
At baseline, adult SHR exhibited a greater number of total horizontal beam breaks compared 
to WKY, but SHR were not different from WIS; WKY exhibited a lower number of total 
beam breaks compared to WIS (Fstrain[2, 29] = 40.4, p<0.0001; Fig 4A). Thus, at baseline, 
WKY were hypoactive relative to both SHR and WIS; and importantly, SHR were not 
hyperactive relative to WIS. Total horizontal beam breaks during adulthood were decreased 
following adolescent MPH treatment in all strains (Ftreatment[1, 29] = 12.3, p<0.01; Fig 4A); 
no strain x treatment interaction was found. With the temporal change of activity analysis, 
number of beam breaks decreased with time in all strains irrespective of treatment history 
(Ftime[11, 319] = 71.1, p<0.0001; Fig 4B). During the first two 5-min bins, SHR made 
greater beam breaks compared to WKY, and WKY made fewer beam breaks compared to 
WIS (Fstrain-treatment combination[5, 319] = 12.3, p<0.0001). Importantly, during the first 5 
minutes of open-field access, SHR with a MPH history, but not with a VEH-treatment 
history, exhibited reduced horizontal beam breaks compared to WIS that received vehicle 
during adolescence (Finteraction[55,319] = 1.50, p<0.05; Fig 4B). Thus, MPH treatment 
during adolescence decreased hyperactivity in adult SHR.
Further evaluation of open-field activity revealed that SHR produced a greater number of 
repeated breaks of the same beam compared to both WKY and WIS (Fstrain[2, 29] = 21.4, 
p<0.0001; Fig 4C). MPH treatment during adolescence reduced the number of repeated 
breaks of the same beam in all adult strains (Ftreatment[1, 29] = 5.54, p<0.05; Fig 4C); no 
strain x treatment interaction was found. Furthermore, adult WKY rats, but not SHRs, were 
found to spend significantly greater time near the margins of the open-field chamber 
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compared to WIS (Fstrain[2, 29] = 15.0, p<0.0001; Fig 4D); SHR were not different from 
WIS. No effects of MPH treatment or strain x treatment interaction were found.
3.3 Cocaine sensitivity
Acute cocaine-induced hyperactivity—Compared to saline, acute cocaine produced 
total horizontal beam breaks in all strains (Fcocaine[1,32] = 14.6, p<0.001; Fig 5); no 
interactions were found. A main effect of strain on activity was found, with SHR and WIS > 
WKY (Fstrain[2, 32] = 21.2; p<0.01), but SHR did not differ from WIS.
SHR exhibited a greater number of repeated breaks of the same beam compared to WKY, 
but not compared to WIS (Fstrain[2, 32] = 11.87; p<0.0001; Supplementary Fig S3). No 
effects of cocaine or MPH treatment history or interaction were revealed.
Induction of cocaine sensitization—A strain x session interaction 
(Fstrain X session[18,56.3] = 6.21; p<0.01), but no interaction of treatment x session or strain x 
treatment x session, were found using the Linear Mixed Model analysis, indicating that 
induction of sensitization differed between strains, but not between treatment groups (Fig 
6A–C). Data for sensitization induction were collapsed across treatment (Fig 6D). Further 
evaluation of the strain x session interaction revealed cocaine sensitization was greater in 
SHR (F[2,344] = 11.9, p<0.0001; the rate of change in photobeam-breaks/session = 1390 ± 
185) compared to WKY and WIS (the rate of change in photobeam-breaks/session = 337 ± 
132 and 445 ± 193, respectively). Using repeated measures ANOVA, treatment x strain x 
session and the treatment x session interactions were not significant. However, the strain x 
session interaction (F[18,261] = 3.21, p<0.001) and the main effect of session (F[9,261] = 
14.4, p<0.001) were significant, which was consistent with the Linear Mixed Model 
analysis. MPH treatment during adolescence did not alter the induction of sensitization to 
repeated cocaine in adult rats. Therefore, sensitization data were collapsed between 
adolescent vehicle and MPH groups. The strain x session interaction was evaluated using 
separate repeated-measures two-way ANOVAs, followed by Dunnett’s post-hoc 
comparisons of the 2nd through 10th sessions to the 1st session of cocaine administration for 
individual strains and followed by Tukey’s test to compare between-strain differences (Fig 
6E). For SHR, activity was elevated (F[9,99] = 15.2, p<0.0001) from the 4th to the 10th 
session compared to the 1st session of repeated cocaine (ps<0.05). For WKY, activity 
differed by session (F[9,90] = 3.64, p<0.001), but Dunnett’s post-hoc analysis did not reveal 
significant pairwise differences compared to the 1st day of repeated cocaine. For WIS, 
activity was not elevated by repeated cocaine injection (F[9,99] = 1.92, p>0.05). Across 
strains, activity in SHR was greater than WKY from the 3rd session to the 10th session, and 
was greater than WIS from the 6th to the 10th session (ps<0.05). Activity in WKY was lower 
than WIS on the 4th, 8th and 10th sessions (ps<0.05). Overall, these results suggest that 
sensitization did not differ with prior MPH treatment, but was differentially induced in SHR 
vs. the WKY and WIS control strains.
Expression of cocaine sensitization—With respect to total horizontal beam breaks, a 
strain x cocaine-dose interaction (Fstrain X cocaine[6,87] = 7.12, p<0.05) and main effect of 
cocaine dose (Fcocaine[3,87] = 28.4, p<0.001) were found; no treatment x strain x cocaine-
Somkuwar et al. Page 9
Pharmacol Biochem Behav. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
dose or treatment x cocaine-dose interactions were found (Fig 7). In SHR, cocaine dose-
dependently increased activity; only the highest dose was different from saline (ps<0.05). In 
contrast, WKY activity was greater with cocaine 7.5 and 15 mg/kg compared to saline, and 
greater with cocaine 15 mg/kg compared to cocaine 5 mg/kg (ps<0.05). For WIS, 15 mg/kg 
produced greater activity than 5 mg/kg, but not saline (p<0.05). Thus, dose-related effects of 
cocaine on sensitization were found for all strains. Following saline injection, activity was 
greater in SHR and WIS compared to WKY (ps<0.05). Following cocaine injections (5–15 
mg/kg), activity was greater in SHR compared to both WKY and WIS (ps<0.05), and the 
control strains were not different from each other. With regard to the number of repeated 
breaks of the same beam, a strain x cocaine-dose interaction (Fstrain X cocaine[6,96] = 4.88, 
p<0.001), the main effect of cocaine dose (Fcocaine[3,96] = 27.0, p<0.0001) and a main 
effect of strain were found (Fstrain[2,32] = 21.8, p<0.0001); treatment x strain x cocaine-dose 
or treatment x cocaine-dose interactions were not found (Fig 8). SHR exhibited a greater 
number of repeated beam breaks compared to both WKY and WIS (ps<0.001). In SHR, 
cocaine dose-dependently increased the number of repeated beam breaks with the highest 
dose being different from saline, 5 mg/kg and 7.5 mg/kg doses (ps<0.05). In contrast, 
repeated beam breaks by WKY were greater with cocaine 7.5 mg/kg and 15 mg/kg 
compared to saline, and greater with cocaine 15 mg/kg compared to cocaine 5 mg/kg 
(ps<0.05). For WIS, 15 mg/kg produced a greater number of repeated beam breaks than 5 
mg/kg, but not compared to saline (p<0.05). Following saline injection, repeated beam 
breaks were greater in SHR and WIS compared to WKY (ps<0.05). Following cocaine 
injections (5, 7.5 and 15 mg/kg), number of repeated beam breaks was greater in SHR 
compared to both WKY and WIS (ps<0.05), and the control strains were not different from 
each other. Thus, dose-related effects of cocaine on sensitization were found for all strains, 
and SHR expressed a greater magnitude of cocaine-induced locomotor activity compared to 
both WKY and WIS.
4 Discussion
To the extent that SHR models ADHD, the current study increases our understanding of the 
long-term consequences of adolescent MPH treatment. ADHD symptoms often decrease in 
severity with age, leading to treatment discontinuation in early adulthood (Mannuzza, Klein 
et al. 1998, Faraone, Biederman et al. 2006, McCarthy, Asherson et al. 2009). Consistent 
with clinical observations, the current study shows that SHR treated chronically with MPH 
during adolescence exhibited decreased hyperactivity during adulthood, observed as a 
decreased total number of beam breaks, particularly during the initial access to the open-
field chambers. These results extend previous reports showing that hyperactivity in 
adolescent outbred Sprague-Dawley rats and adolescent SHR was reduced during acute and 
sub-chronic MPH treatment during adolescence (Kuczenski and Segal 2002, Umehara, Ago 
et al. 2013, Umehara, Ago et al. 2013). Furthermore, adolescent MPH treatment was found 
to decrease other aspects of SHR hyperactivity, specifically stereotypic behavior inferred 
from repeated breaks of the same photobeam in the open-field chambers. Importantly, the 
effects of MPH treatment history was not generalized to all types of open field behavior as 
evidenced by the amount of time spent near the margins as opposed to the center of the box, 
which is an indication of stress/anxiety. With respect to increased locomotor activity in SHR 
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relative to WKY, a study evaluating monoamine transporter inhibitors (i.e., selective NET 
inhibitors: desipramine, reboxetine and atomoxetine; selective SERT inhibitor: citalopram) 
revealed that inhibitor-induced decreases in hyperactivity in SHR are associated with 
increased extracellular DA and NE, but not 5-HT in mPFC microdiaysate (Umehara, Ago et 
al. 2013). In WKY, increased immobility (depression-like behavior) in a forced-swim 
paradigm, relative to WIS controls, was associated with increased hippocampal NE, 5-HT 
and glutamate, and importantly, increased NE and 5-HT in frontal cortex (Jastrzebska, 
Frankowska et al. 2015). Collectively, these findings suggest that functional alterations in 
several neurotransmitters in prefrontal cortex and other brain regions may underlie the 
hyperactivity and response to stress in SHR relative to control strains. Thus, hyperactivity in 
the SHR may be due to elevated DA and NE relative to the control strains, and MPH 
treatment during adolescence may have normalized the hyperactivity in SHR by producing 
lasting adaptations in DA and NE in prefrontal cortex.
In the SHR, the MPH treatment regimen maintained the low response efficiency under both 
DRL schedules herein. While response efficiency is an accepted index of impulsivity, it was 
~2.5% in SHR compared to 30% and 10% in WKY and WIS, respectively, suggesting a 
floor effect for SHR under DRL30. When only response efficiency is considered, a 
comprehensive understanding of DRL30 behavior is not obtained (Richards, Sabol et al. 
1993), as efficiency does not differentiate between errors due to response inhibition and 
timing. Mathematical modeling of the IRT data employing theoretically based measures of 
response inhibition capacity more accurately describes DRL behavior (Sanabria and Killeen 
2008, Hill, Covarrubias et al. 2012). In the current study, SHR exhibited reduced response 
inhibition capacity (increased burst IRTs and reduced accuracy under DRL30). Moreover, 
the more comprehensive evaluation of SHR responding under DRL revealed an important 
effect of MPH treatment and discontinuation, the exacerbation of response inhibition deficits 
(increased burst/decreased timed IRTs), which was not apparent when measuring response 
efficiency. Thus, while discontinuation of adolescent MPH treatment produced a long-term 
reduction in hyperactivity in adult SHR, an unanticipated adverse consequence was an 
enhancement of impulsivity.
Impulsivity, including response inhibition deficits under DRL, is associated with decreased 
DA function in prefrontal cortex of adult outbred rats (Sokolowski and Salamone 1994, 
Peterson, Wolf et al. 2003, Antonelli, Ko et al. 2013, Pardey, Kumar et al. 2013, Simon, 
Beas et al. 2013). Both DAT and NET clear extracellular DA in prefrontal cortex (Moron, 
Brockington et al. 2002, Berridge, Devilbiss et al. 2006). In adult SHR, NET function in 
orbitofrontal cortex (OFC; a subregion of the prefrontal cortex) is increased compared to 
WKY and WIS (Somkuwar, Kantak et al. 2015). Also, MPH treatment during adolescence 
normalized NET function in adult SHR. Thus, elevated NET function in the absence of 
MPH treatment may contribute to decreased extracellular DA and/or decreased DA receptor 
signaling in OFC. Reduction in DA receptor availability in the OFC was negatively 
correlated with response inhibition capacity in humans (Albrecht, Kareken et al. 2014). 
Inhibition of NET by local infusion of atomoxetine into OFC improved response inhibition 
capacity in rats (Bari, Mar et al. 2011). These results suggest that increased NET function 
may underlie, at least in part, the increase in impulsivity in SHR compared to controls. 
However, impulsivity was not normalized with MPH treatment during adolescence, 
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suggesting that alternate mechanisms (e.g., serotonin function) may be responsible for the 
MPH-mediated increase in impulsivity in adult SHRs reported herein.
Serotonergic neurotransmission has been implicated in the control of impulsive behavior 
(Pattij and Vanderschuren 2008). In mPFC, 5-HT release positively correlated with 
premature responding on a 1-choice serial reaction time task in outbred Lister-hooded rats 
(Dalley, Theobald et al. 2002). Using DRL schedules with relatively long wait-times similar 
to those employed herein, 5-HT2A receptor antagonists increased efficiency in outbred 
Sprague-Dawley rats, whereas 5-HT1B receptor knockout mice exhibited decreased 
efficiency (Pattij, Broersen et al. 2003, Anastasio, Stoffel et al. 2011). 5-HT release from 
cortical slices taken during both adolescence and adulthood did not differ between SHR, 
WKY and WIS rats (Schlicker, Classen et al. 1988). Moreover, discontinuation of 
adolescent MPH treatment (2 mg/kg/day, i.p.; either PND 25–39 or PND 50–64) did not 
result in long term alterations in striatal 5-HT transporter density in adult SHR and WKY 
(Roessner, Manzke et al. 2009). Thus, 5-HT does not appear to play a critical role in strain 
differences with respect to impulsivity. However, it is possible that alterations in 5-HT 
function specifically in prefrontal cortex may be involved in the increased impulsivity 
(burst-responses in DRL30) observed following discontinuation of MPH treatment (current 
study).
Age-dependent decreases in impulsivity are associated with developmental maturation of 
prefrontal cortical DA systems in rats and humans (Brenhouse, Sonntag et al. 2008, Burton 
and Fletcher 2012, Rothmond, Weickert et al. 2012). In SHR, MPH during adolescence 
increases mPFC DAT function in adults relative to vehicle control (Somkuwar, Darna et al. 
2013). Faster mPFC DA clearance is expected to reduce DA transmission, consistent with 
increased impulsivity (increased burst responding and decreased efficiency) under DRL30 
(Sokolowski and Salamone 1994). MPH during adolescence did not alter mPFC DAT 
function or increase impulsivity in WKY and WIS controls (Somkuwar et al. 2013; current 
study). Thus, an underlying mechanism mediating increased response inhibition deficits in 
SHR given MPH during adolescence likely involves the mPFC DA system.
Acute cocaine produces hyperactivity and behavioral sensitization following repeated 
injection in SHR, WKY and WIS (Cailhol and Mormede 1999, Frankowska, Nowak et al. 
2009). MPH pretreatment (2.5 mg/kg/day i.p., for 10 days) administered outside the home 
cage during adolescence or early adulthood was reported to increase cocaine cross-
sensitization evaluated 10 days after MPH in SHR compared to WKY and outbred Sprague-
Dawley rats (Yetnikoff and Arvanitogiannis 2013). In contrast, home-cage administration of 
MPH (0.6 or 2.5 mg/kg/day i.p. for 6 days) did not alter sensitization to MPH in adolescent 
or adult SHR (Yang, Swann et al. 2006, Yang, Cuellar et al. 2011). The current study 
extends previous findings by employing a therapeutically relevant MPH dose and home-
cage administration of MPH, and shows that treatment history did not alter cocaine 
sensitization during adulthood. Thus, independent of adolescent MPH treatment, SHR 
exhibited robust sensitization following repeated cocaine compared to control strains, 
revealing a strain-dependent vulnerability.
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One explanation for these results may be differences in baseline locomotor activities 
between strains. For total number of horizontal beam breaks at baseline, SHR are 
hyperactive compared to WKY, but SHR are not different from WIS (Fig. 4A). As such, the 
baseline is higher in SHR and WIS, relative to WKY overall. If the effects of cocaine were 
dependent on the baseline rate, one would expect that WIS should react the same way as 
SHR, but this was not the case. Thus, the response to cocaine was not dependent on 
baseline. However, investigation of the behavior as repeated beam breaks of the same beam, 
interpreted as stereotypic behavior, provides a somewhat different perspective. Strain 
differences in stereotypic behavior were found with SHR > WKY and WIS (Fig. 4C). As 
such, one caveat is that the current study does not address whether in the absence of repeated 
cocaine injection, continued exposure to the open-field apparatus alters horizontal beam 
breaks activity differently in SHR compared to controls strains, and between MPH and 
vehicle treatment histories. In this regard, temporal changes in horizontal activity observed 
during a single session (Fig 4B) shows that strain differences in hyperactivity dissipated 
over prolonged exposure. Similar effects are expected with repeated exposure to an open-
field chamber over days. Recently, strain differences in sensitization following 10 repeated 
MPH or saline injections revealed that locomotor activity for saline-treated SHR and WKY 
were not different (Yetnikoff and Arvanitogiannis 2013). Nonetheless, locomotor 
hyperactivity at baseline was not different between SHR and WIS, yet cocaine sensitization 
was greater in SHR, indicating that differences in behavior in cocaine-treated animals is not 
likely due to differences in baseline activity.
Expression of sensitization depends on increased glutamatergic transmission (Pierce, Bell et 
al. 1996, Perez, Gabach et al. 2010), increased DAT function and reduced D2 function 
(Mandt and Zahniser 2010, Merritt and Bachtell 2013) in striatum. SHR are less sensitive to 
glutamate-stimulated striatal DA and acetylcholine release, exhibit greater striatal DAT 
function and reduced D2 function compared to WKY and outbred rats (Tsuda, Tsuda et al. 
1996, Fujita, Okutsu et al. 2003, Russell 2003, Miller, Pomerleau et al. 2012). These results 
suggest that the deficient striatal glutamatergic and DA function in SHR underlies the 
enhanced induction of cocaine sensitization. The lack of effect of adolescent treatment with 
MPH (1.5 mg/kg, p.o.) on cocaine sensitization may be partly due to the lack of effect of this 
dose on striatal DAT function (Somkuwar, Darna et al. 2013). This finding in SHR is 
complementary to clinical studies on ADHD showing no evidence for cocaine sensitization 
in adolescents and young adults that had been treated with MPH in childhood (Humphreys, 
Eng et al. 2013).
The current study highlights the persistence of some of the beneficial effects of adolescent 
MPH treatment with respect to decreased hyperactivity (both horizontal activity and 
stereotypy) during adulthood. These preclinical results align with the observed beneficial 
effects of stimulant treatment following early recognition and favorable long-term outcome 
in adult ADHD patients (Fredricksen, Halmoy et al, 2013). However, clinical studies 
suggest that initiation of MPH treatment during late childhood or early adolescence may 
increase the risk of substance use disorder in adulthood (Mannuzza, Klein et al. 2008, 
Dalsgaard, Mortensen et al. 2014), which is not an outcome associated with MPH treatment 
initiated earlier in childhood (Humphreys, Eng et al. 2013, Molina, Hinshaw et al. 2013). 
Conclusions from these clinical studies, that an increase in SUD risk that occurs when MPH 
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treatment begins in late childhood/early adolescence, also are consistent with other 
preclinical work showing that SHR treated with MPH during adolescence increases cocaine 
self-administration in adulthood even if treatment is discontinued after adolescence (Harvey, 
Sen et al. 2011, Baskin, Dwoskin et al. 2015).
Cocaine abuse vulnerability is linked to increased response inhibition deficits (Fillmore and 
Rush 2002, Li, Milivojevic et al. 2006). Response inhibition deficits are suggested to 
underlie the greater cocaine abuse liability in ADHD as well (Everitt, Belin et al. 2008, 
Groman, James et al. 2009, Winstanley, Olausson et al. 2010). Individuals with comorbid 
ADHD and cocaine dependence exhibit greater response inhibition deficits compared to 
those with ADHD without cocaine dependence, and compared to control (Crunelle, Veltman 
et al. 2013). Thus, the enhanced cocaine abuse vulnerability we previously observed in adult 
SHR receiving adolescent MPH treatment (Harvey, Sen et al. 2011, Baskin, Dwoskin et al. 
2015) may be mediated, in part, by the reductions in response inhibition capacity observed 
herein. Although the role of previous medication status on response inhibition capacity in 
adults with ADHD has not been evaluated comprehensively, the current results in SHR 
suggest that adolescent MPH treatment may increase aspects of impulsivity in adults after 
adolescent MPH is discontinued.
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Highlights
• Lasting effects of discontinued adolescent methylphenidate treatment are 
reported
• Treatment decreased hyperactivity in adulthood in SHR, a model of ADHD
• Treatment discontinuation increased impulsivity in adult SHR compared to 
vehicle
• Treatment discontinuation had no effects on cocaine sensitivity in SHR or 
control
• SHR show greater impulsivity, hyperactivity and cocaine sensitization than 
controls
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Fig 1. 
Schematic of treatments and conduct of experiments.
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Fig 2. 
Under DRL5LH, discontinuation of chronic methylphenidate (MPH) treatment following 
adolescence did not alter response inhibition capacity in adult SHR. Mean inter-response 
time (IRT) distributions were not different between MPH (dotted curves) and vehicle (VEH, 
solid curves) groups, except for WKY (middle panel). Mean IRT distributions are presented 
as 1-s moving averages of IRTs for SHR, WKY and WIS under DRL5LH. n = 5–6/group.
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Fig 3. 
Under DRL30, discontinuation of chronic methylphenidate (MPH) treatment following 
adolescence increased the response inhibition deficit in adult SHR. (A) In adult SHR (right 
panel), but not in control strains, discontinuation of adolescent treatment with MPH (dotted 
curves) altered inter-response time (IRT) distribution by increasing burst IRTs and 
proportionately decreasing timed IRTs. (B) Compared to WKY and WIS rats, adult SHR 
under the DRL30 schedule exhibited reduced accuracy of timed IRTs (mean ± S.E.M.) 
irrespective of adolescent treatment with MPH (gray bars) or vehicle (VEH, white bars). 
Also, accuracy of timed IRTs was reduced in WIS compared to WKY. (C) Compared to 
WKY and WIS, adult SHR administered VEH during adolescence emitted a greater 
proportion of burst IRTs (mean ± S.E.M.). MPH treatment during adolescence further 
increased burst IRTs during adulthood. Mean IRT distributions are presented as 5-s moving 
averages of IRTs for SHR, WKY and WIS under DRL30. n = 5–6/group; † p≤0.05 
compared to the respective VEH control and MPH-treated WKY and WIS; ^ p≤0.05 
compared to VEH-treated WKY and WIS; * p≤0.05 main effect of strain, different from 
WKY and WIS; # p≤0.05 main effect of strain, different from WIS.
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Fig 4. 
Discontinuation of chronic methylphenidate (MPH, grey bars) treatment following 
adolescence decreased hyperactivity in adult SHR. (A) SHR exhibited greater total 
horizontal beam breaks (mean ± S.E.M.) compared to WKY, while that by adult WKY was 
fewer compared to WIS rats. (B) Adult SHR that received MPH during adolescence (closed 
diamonds), but not SHR administered vehicle (VEH; open diamonds) during adolescence, 
showed reduced horizontal beam breaks during the first 5-min bin compared to adult WIS 
rats that received VEH during adolescence (open squares). (C) SHR exhibited greater 
repeated breaks of the same beam in open-field chambers compared to WKY and WIS rats. 
(D) Time spent near the margins was increased in WKY compared to both WIS and SHR. 
Finally, discontinuation of adolescent treatment with MPH (gray bars) decreased both total 
number of beam breaks (A) and repeated breaks of the same beam (C) in adult rats 
compared to vehicle control (VEH, white bars). n = 5–6/group; * p≤0.05 compared to all 
other strains; # p≤0.05 compared to WIS; ^ p≤0.05 compared to WKY; $ p≤0.05 compared 
to WIS-VEH.
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Fig 5. 
Acute cocaine injection induced hyperactivity in adult WIS, WKY rats and SHR compared 
to saline injection. Discontinuation of methylphenidate (MPH; gray bars) and vehicle (VEH; 
white bars) treatments did not alter cocaine-induced hyperactivity in WIS, WKY and SHR. 
Values are mean ± S.E.M. for number of horizontal photobeam breaks. Saline data reflects 
locomotor activity for 1 hour following the injection on the day after habituation. n = 5–6/
group; *p<0.05 main effect of cocaine, compared to respective saline control.
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Fig 6. 
Repeated cocaine (10 mg/kg, i.p.) injection induced sensitization in adult SHR, but not in 
adult WIS or WKY rats. Discontinuation of methylphenidate (MPH; white symbols) and 
vehicle (VEH; gray symbols) treatments did not alter cocaine-induced hyperactivity in WIS, 
WKY and SHR. Values are mean ± S.E.M. for number of horizontal photobeam breaks 
following cocaine injections for sessions 1–10. n = 5–6/group (A–C). Linear regressions (D) 
and observed data (E) for induction of sensitization for cocaine for individual strains 
(collapsed across VEH and MPH groups) are presented. n = 11–12/strain; *p<0.05 
compared to WKY and WIS, ^p<0.05 compared to WKY, #p<0.05 compared to 1st session 
of SHR.
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Fig 7. 
Cocaine (5–15 mg/kg, i.p.) dose-dependently increased hyperactivity in adult WIS, WKY 
rats and SHR compared to saline injection. Discontinuation of methylphenidate (MPH; gray 
bars) and vehicle (VEH; white bars) treatments did not alter expression of cocaine-
sensitization in WIS, WKY and SHR. Cocaine sensitivity was greater in SHR compared to 
both WKY and WIS, at all doses except saline at which activity was greater in SHR and 
WIS compared to WKY. Values are mean ± S.E.M. for number of horizontal photobeam 
breaks. Saline data reflects locomotor activity for 30 min following 14 days of no cocaine 
administration after the induction of cocaine sensitization. n = 5–6/group; * p<0.05 
compared to saline; # p<0.05 compared to 5 mg/kg cocaine; ^ p<0.05 compared to 7.5 
mg/kg cocaine.
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Fig 8. 
Cocaine (5–15 mg/kg, i.p.) dose-dependently increased hyperactivity in adult WIS, WKY 
rats and SHR compared to saline injection. Discontinuation of methylphenidate (MPH; gray 
bars) and vehicle (VEH; white bars) treatments did not alter expression of cocaine-
sensitization in WIS, WKY and SHR. Repeated breaks of the same beam were greater in 
SHR than WKY at all doses and greater than WIS at the two highest cocaine doses only. 
Values are mean ± S.E.M. for number of horizontal photobeam breaks. Saline data reflects 
locomotor activity for 30 min following 14 days of no cocaine administration after the 
induction of cocaine sensitization. n = 5–6/group; * p<0.05 compared to saline; # p<0.05 
compared to 5 mg/kg cocaine; ^ p<0.05 compared to 7.5 mg/kg cocaine.
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